COMMISSION IMPLEMENTING DECISION

of 12 November 2013

as regards a Union financial aid towards a coordinated control plan for antimicrobial resistance monitoring in zoonotic agents in 2014

(notified under document C(2013) 7289)

(2013/653/EU)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules(1), and in particular Article 66 thereof,

Having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002(2) (the Financial Regulation), and in particular Article 84(2) thereof,

Whereas:

(1) Regulation (EC) No 882/2004 lays down, among others, procedures governing the financial support from the Union to conduct measures necessary to ensure the application of Regulation (EC) No 882/2004.

(2) Directive 2003/99/EC of the European Parliament and of the Council(3) provides that Member States shall ensure that monitoring provides comparable data on the occurrence of antimicrobial resistance (AMR) in zoonotic agents and, in so far as they present a threat to public health, other agents.

(3) Article 7(3) of this Directive provides that the Commission shall set out detailed rules for the implementation of monitoring of antimicrobial resistance.

(4) Several scientific opinions published by the European Food Safety Authority and reports published by the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO) and the World Animal Health Organisation (OIE) call for a harmonised monitoring of antimicrobial resistance (AMR) in zoonotic and commensal bacteria, present in animals or food. The Commission therefore laid down detailed rules for harmonised monitoring and reporting of AMR in accordance with Article 7(3) of Directive 2003/99/EC to be carried out by the Member States in Commission Implementing Decision 2013/652/EU(4).

(5) This harmonised monitoring must be performed in accordance with Article 3 of Regulation (EC) No 882/2004 ensuring that official controls are carried out regularly, on a risk basis and with appropriate frequency, so as to achieve the objectives of that Regulation taking account of identified risks associated with animals, feed or food, feed or food businesses, the use of feed or food or any process, material, substance, activity or operation that may influence feed or food safety, animal health or animal welfare.

(6) In order to facilitate smooth and fast application of this monitoring, the Union should financially support the Member States which carry out this monitoring at the most appropriate level as provided for in Article 66(1)(c) of Regulation (EC) No 882/2004.

(7) In accordance with Article 84 of the Financial Regulation and Article 94 of the Commission Delegated Regulation (EU) No 1268/2012(5), the commitment of expenditure from the Union budget shall be preceded by a financing decision setting out the essential elements of the action involving expenditure and adopted by the institution or the authorities to which powers have been delegated by the institution.

(8) The measures eligible for Union financial support are defined within the current Implementing Decision.

(9) The financial contribution from the Union should be granted subject to the condition that the tests and analyses have been carried out in accordance with the present Implementing Decision and with Implementing Decision 2013/652/EU and that the competent authorities supply all the necessary information within the time limits laid down in the present Implementing Decision.

(10) For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro and the conversion rate for expenditure in a currency other than the euro should be set,

HAS ADOPTED THIS DECISION:

Article 1

Subject matter

The Union shall contribute to the costs incurred by the Member States relating to the application of the harmonised antimicrobial resistance monitoring in accordance with Implementing Decision 2013/652/EU on samples of poultry collected between 1 January and 31 December 2014, with a total maximum amount of EUR 1 407 585 to be financed from line 17 04 07 01.

Article 2

Eligible costs

The Union financial contribution:

(a) shall be at a rate of 50 % of the costs incurred by each Member State to implement the monitoring referred to in Article 1 of Implementing Decision 2013/652/EU and performed by the competent authority;

(b) shall not exceed the following:

(i) EUR 8 for staff costs per caecal sampling;

(ii) EUR 11 per

E. coli

isolation and identification;

(iii) EUR 21,5 per

Campylobacter

isolation and identification;

(iv) EUR 15 per antimicrobial susceptibility testing (AST) of each

Salmonella

E. coli

isolate;

(v) EUR 15 per AST of each

Campylobacter

isolate;

(vi) EUR 17,5 per characterisation and classification of

Salmonella

E. coli

isolates showing resistance to third-generation cephalosporins and meropenem;

(vii) EUR 22 per

Salmonella

serotyping;

(viii)

the maximum amounts indicated in Annex I;

Article 3

Eligibility rules

1. The Union contribution is subject to the following conditions:

(a) by 31 May 2015, the Member States have provided to the European Food Safety Authority who was mandated for this task by the European Commission, with a technical report covering at least the information requested in Part B of the Annex to Implementing Decision 2013/652/EU;

(b) by 31 May 2015, the Member States have provided the Commission, in electronic form, with a financial report according to the format laid out in Annex III to this Decision. In order to be eligible for funding, the expenditure incurred must have been paid before the submission of the claim. The supporting documents evidencing all the expenditure referred to in the financial report shall be sent to the Commission on request only.

2. The Commission may reduce the amount of the contributions referred to in Annex I in cases where the conditions referred to in paragraph 1 of this Article are not met, having regard to the nature and gravity of the non-compliance and to the potential financial loss for the Union.

Article 4

Conversion rate for expenditure

For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro. When a Member State’s expenditure is in a currency other than euro, the Member State shall convert it into euro by applying the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State concerned.

Article 5

This Decision constitutes a financing decision in the meaning of Article 84 of Regulation (EU, Euratom) No 966/2012.

Article 6

This Decision is addressed to the Member States.

Done at Brussels, 12 November 2013.

For the Commission

Tonio BORG

Member of the Commission

(1)

OJ L 165, 30.4.2004, p. 1

(2)

OJ L 298, 26.10.2012, p. 1

(3) Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses and zoonotic agents (

OJ L 325, 12.12.2003, p. 31

(4) Commission Implementing Decision 2013/652/EU of 12 November 2013 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria (see page 26 of this Official Journal).

(5) Commission Delegated Regulation (EU) No 1268/2012 of 29 October 2012 on the rules of application of Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council on the financial rules applicable to the general budget of the Union (

OJ L 362, 31.12.2012, p. 1

ANNEX I

Table 1

Member States	Number of
	Caecal samples	Isolation/Identification & AST		AST Salmonella	Serotyping Salmonella	Characterisation and classification of resistant isolates
	Caecal samples	Campylobacter	E. coli	AST Salmonella	Serotyping Salmonella	Characterisation and classification of resistant isolates
BE	850	170	170	550	550	150
BG	425	85	85	200	200	50
CZ	850	170	170	550	550	150
DK	850	170	170	250	250	100
DE	1 700	340	340	700	700	200
EE	425	85	85	100	100	50
IE	850	170	170	300	300	100
EL	850	170	170	450	450	100
ES	1 700	340	340	1 000	1 000	250
FR	1 700	340	340	800	800	250
HR	425	85	85	250	250	100
IT	1 700	340	340	800	800	250
CY	425	85	85	200	200	100
LV	425	85	85	100	100	50
LT	425	85	85	200	200	50
LU	425	85	85	100	100	50
HU	1 700	340	340	900	900	250
MT	425	85	85	100	100	50
NL	850	170	170	450	450	150
AT	1 700	340	340	550	550	200
PL	1 700	340	340	800	800	250
PT	1 700	340	340	500	500	200
RO	850	170	170	600	600	150
SI	425	85	85	200	200	50
SK	425	85	85	100	100	50
FI	850	170	170	50	50	50
SE	850	170	170	50	50	50
UK	1 700	340	340	800	800	250
Total	27 200	5 440	5 440	11 650	11 650	3 700

Table 2

Member States	Maximum reimbursement (EUR)
	Caecal sampling	E. coli Isolation & identification	Campylobacter Isolation & identification	Salmonella serotyping	AST		Characterisation & classification resistant isolates	Total	Overheads included (7 %)
	Caecal sampling	E. coli Isolation & identification	Campylobacter Isolation & identification	Salmonella serotyping	Salmonella + E. coli	Campylobacter	Characterisation & classification resistant isolates	Total	Overheads included (7 %)
BE	6 800	2 200	14 800	14 700	10 800	2 600	2 700	54 600	58 422
BG	500	2 200	8 600	5 700	4 000	1 300	900	23 200	24 824
CZ	1 600	1 300	9 100	7 200	8 800	1 200	1 900	31 100	33 277
DK	6 800	2 200	18 300	9 300	6 300	2 600	1 800	47 300	50 611
DE	13 600	4 400	36 600	22 900	14 100	4 400	3 500	99 500	106 465
EE	400	1 000	3 300	4 100	2 200	1 100	200	12 300	13 161
IE	5 900	1 200	11 400	8 700	5 000	1 400	1 200	34 800	37 236
EL	2 000	2 200	14 900	7 700	8 500	2 600	1 300	39 200	41 944
ES	5 200	1 800	14 600	29 500	20 100	5 100	4 400	80 700	86 349
FR	13 600	4 400	36 600	25 100	17 100	4 100	4 400	105 300	112 671
HR	2 000	2 200	500	6 500	5 100	1 300	1 200	18 800	20 116
IT	13 600	4 400	25 000	16 500	12 200	3 700	2 700	78 100	83 567
CY	1 400	2 200	9 200	6 300	3 800	1 000	1 300	25 200	26 964
LV	700	900	3 400	3 900	1 600	800	500	11 800	12 626
LT	400	2 000	4 900	2 900	3 200	600	600	14 600	15 622
LU	3 400	2 200	9 200	4 100	2 800	1 300	900	23 900	25 573
HU	3 600	2 500	29 600	25 000	13 100	4 000	2 900	80 700	86 349
MT	1 300	500	5 500	3 500	2 000	700	900	14 400	15 408
NL	6 800	1 300	12 500	7 100	7 900	2 600	2 700	40 900	43 763
AT	13 600	4 400	36 600	17 000	13 400	5 100	3 500	93 600	100 152
PL	6 200	2 200	17 800	17 700	7 700	3 600	1 900	57 100	61 097
PT	4 400	3 900	36 600	18 500	5 600	2 100	1 700	72 800	77 896
RO	6 800	1 500	9 000	17 000	11 600	2 600	2 700	51 200	54 784
SI	3 400	1 900	9 200	5 200	2 700	1 300	900	24 600	26 322
SK	1 600	2 000	9 200	3 300	2 800	1 300	900	21 100	22 577
FI	6 800	1 900	8 300	0	3 300	2 300	900	23 500	25 145
SE	6 800	1 300	10 700	4 900	3 000	2 400	600	29 700	31 779
UK	13 600	3 600	36 600	25 100	17 100	5 100	4 400	105 500	112 885
Total	152 800	63 800	442 000	319 400	215 800	68 200	53 500	1 315 500	1 407 585

ANNEX II

ELIGIBILITY RULES

1. Laboratory costs

— Staff costs shall be limited to actual attributable labour costs (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.

— Reimbursement of consumables shall be based on actual costs incurred by Member States to perform the tests at the laboratory designated by the competent authority.

— Test kits, reagents and all other consumables shall only be reimbursed if used specifically in the performance of the following tests:

(i) E. coli

isolation and identification;

(ii) Campylobacter

isolation and identification;

(iii) AST of

Salmonella

and

E. coli

isolates;

(iv) AST of

Campylobacter

isolates;

(v) Characterisation and classification of

Salmonella

and

E. coli

isolates showing resistance to third-generation cephalosporins and meropenem;

(vi) Salmonella

serotyping.

2. Sampling costs

Costs for sampling shall be limited to staff costs of work within the slaughterhouse for the actual attributable labour (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.

3. Overheads

A flat rate contribution of 7 % calculated on the basis of all direct eligible costs may be claimed.

4. The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax (VAT) and all other taxes.

ANNEX III

TEMPLATE FOR FINANCIAL REPORTS AS REFERRED TO IN ARTICLE 3(1)(B)

Reporting period: 2014

Member State: …

Reference number of Commission Implementing Decision providing a financial contribution from the Union: 2013/653/EU

Laboratory costs (total effective eligible costs)

E. coli isolation and identification
Staff category	Number of working hours	Rate (EUR per hour)	Total (EUR)
…
…

Consumables (description)	Quantity	Unit cost (EUR)	Total (EUR)
…
…
		Total (EUR)
Total nr of tests:		Unit cost per analysis (EUR)
Campylobacter isolation and identification
Staff category	Number of working hours	Rate (EUR per hour)	Total (EUR)
…
…

Consumables (description)	Quantity	Unit cost (EUR)	Total (EUR)
…
…
		Total (EUR)
Total nr of tests:		Unit cost per analysis (EUR)
AST Salmonella and E. coli isolates
Staff category	Number of working hours	Rate (EUR per hour)	Total (EUR)
…
…

Consumables (description)	Quantity	Unit cost (EUR)	Total (EUR)
…
…
		Total (EUR)
Total nr of tests:		Unit cost per analysis (EUR)
AST Campylobacter isolates
Staff category	Number of working hours	Rate (EUR per hour)	Total (EUR)
…
…

Consumables (description)	Quantity	Unit cost (EUR)	Total (EUR)
…
…
		Total (EUR)
Total nr of tests:		Unit cost per analysis (EUR)
Characterisation and classification of resistant isolates
Staff category	Number of working hours	Rate (EUR per hour)	Total (EUR)
…
…

Consumables (description)	Quantity	Unit cost (EUR)	Total (EUR)
…
…
		Total (EUR)
Total nr of tests:		Unit cost per analysis (EUR)
Salmonella serotyping
Staff category	Number of working hours	Rate (EUR per hour)	Total (EUR)
…
…

Consumables (description)	Quantity	Unit cost (EUR)	Total (EUR)
…
…
		Total (EUR)
Total nr of tests:		Unit cost per analysis (EUR)

Sampling costs (total effective eligible costs)

Staff category	Number of working hours	Rate (EUR per hour)	Total (EUR)
…
…



		Total (EUR)
Total nr of samples:		Unit cost per sample (EUR)

Total expenditure for the coordinated control programme (real costs, VAT excluded) (EUR):

…

Declaration by the beneficiary

We certify that:

— the expenditure listed above was incurred in the performance of tasks described in Implementing Decision 2013/652/EU and directly related to the implementation of the coordinated control plan for which financial support was granted according to Implementing Decision 2013/653/EU;

— the expenditure was actually incurred, paid by the submission date of the current claim, accurately accounted for and eligible under the provisions of Implementing Decision 2013/653/EU;

— all supporting documents supporting for the costs are available for audit purposes;

— no other contribution from the Union was requested for this coordinated control plan.

Date: …

Person responsible: …

Signature: …